BCRX Greek Exposure

BCRX is BIOCRYST PHARMACEUTICALS, a Healthcare company with a $1.86B market cap. Gamma (GEX) highlights support/resistance from dealer hedging, Delta (DEX) shows bullish vs bearish bets, Vanna tracks volatility-driven flows, and Charm shows time-decay hedging. Analyze exposure by strike and expiration to find key price levels.

Name
BIOCRYST PHARMACEUTICALS
Type
Common Stock
Sector
Healthcare
Market cap
$1.86B
Avg. daily volume (30d)
5.04M
Next earnings
2027-02-25

Frequently asked questions

What is BCRX gamma exposure (GEX)?
Gamma exposure (GEX) measures how much market makers must hedge when BCRX stock moves. Positive GEX means dealers are long gamma and will hedge in a stabilizing way (buy dips, sell rallies), while negative GEX means their hedging amplifies moves.
What is BCRX delta exposure (DEX)?
Delta exposure (DEX) shows the net directional options exposure on BCRX. It represents how many shares market makers need to buy or sell to stay delta-neutral. Large DEX shifts can indicate significant directional positioning.
How do BCRX Vanna and Charm affect the stock?
Vanna measures how BCRX option deltas change with implied volatility — when IV drops, positive vanna exposure forces dealers to buy shares, creating upward pressure. Charm measures delta decay over time, causing similar hedging flows as options approach expiration.